Mechanisms and strategies of papillomavirus replication

Biological Chemistry

Volumn 398, Issue 8, 2017, Pages 919-927

  McBride, Alison A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

DNA damage response; DNA replication; HPV; human papillomavirus; partitioning; recombination dependent replication

Indexed keywords

VIRAL PROTEIN;

ARTICLE; DNA REPLICATION ORIGIN; GENE AMPLIFICATION; GENE STRUCTURE; MOLECULAR EVOLUTION; NONHUMAN; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION; ANIMAL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; GENOME, VIRAL; HUMANS; PAPILLOMAVIRIDAE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 85023161082     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2017-0113     Document Type: Article

References (88)

1. Anacker, D.C. and Moody, C.A. (2017). Modulation of the DNA damage response during the life cycle of human papillomaviruses. Virus Res. 231, 41-49.
2. Archambault, J. and Melendy, T. (2013). Targeting human papillomavirus genome replication for antiviral drug discovery. Antivir. Ther. 18, 271-283.
3. Aydin, I., Weber, S., Snijder, B., Samperio Ventayol, P., Kuhbacher, A., Becker, M., Day, P.M., Schiller, J.T., Kann, M., Pelkmans, L., et al. (2014). Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog. 10, e1004162.
4. Banerjee, N.S., Wang, H.K., Broker, T.R., and Chow, L.T. (2011). Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J. Biol. Chem. 286, 15473-15482.
5. Bastien, N. and McBride, A.A. (2000). Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology 270, 124-134.
6. Baxter, M.K., McPhillips, M.G., Ozato, K., and McBride, A.A. (2005). The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol. 79, 4806-4818.
7. Becker, K.A., Florin, L., Sapp, C., and Sapp, M. (2003). Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology 314, 161-167.
8. Bergvall, M., Melendy, T., and Archambault, J. (2013). The E1 proteins. Virology 445, 35-56.
9. Cubie, H.A. (2013). Diseases associated with human papillomavirus infection. Virology 445, 21-34.
10. Day, P.M., Baker, C.C., Lowy, D.R., and Schiller, J.T. (2004). Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad Sci. USA 101, 14252-14257.
11. Day, P.M., Thompson, C.D., Schowalter, R.M., Lowy, D.R., and Schiller, J.T. (2013). Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J. Virol. 87, 3862-3870.
12. DiGiuseppe, S., Luszczek, W., Keiffer, T.R., Bienkowska-Haba, M., Guion, L.G., and Sapp, M.J. (2016). Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis. Proc. Natl. Acad Sci. USA 113, 6289-6294.
13. Donaldson, M.M., Mackintosh, L.J., Bodily, J.M., Dornan, E.S., Laimins, L.A., and Morgan, I.M. (2012). An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment. J. Virol. 86, 12806-12815.
14. Doorbar, J. (2013). Latent papillomavirus infections and their regulation. Curr. Opin. Virol. 3, 416-421.
15. Dreer, M., van de Poel, S., and Stubenrauch, F. (2016). Control of viral replication and transcription by the papillomavirus E8-E2 protein. Virus Res. 231, 96-102.
16. Egawa, N., Egawa, K., Griffin, H., and Doorbar, J. (2015). Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses 7, 3863-3890.
17. Enemark, E.J. and Joshua-Tor, L. (2006). Mechanism of DNA translocation in a replicative hexameric helicase. Nature 442, 270-275.
18. Everett, R.D. (2006). Interactions between DNA viruses, ND10 and the DNA damage response. Cell. Microbiol. 8, 365-374.
19. Favre, M., Breitburd, F., Croissant, O., and Orth, G. (1977). Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses. J. Virol. 21, 1205-1209.
20. Florin, L., Schafer, F., Sotlar, K., Streeck, R.E., and Sapp, M. (2002). Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology 295, 97-107.
21. Fradet-Turcotte, A., Bergeron-Labrecque, F., Moody, C.A., Lehoux, M., Laimins, L.A., and Archambault, J. (2011). Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J. Virol. 85, 8996-9012.
22. Gao, G., Johnson, S.H., Vasmatzis, G., Pauley, C.E., Tombers, N.M., Kasperbauer, J.L., and Smith, D.I. (2017). Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma. Genes Chromosomes Cancer 56, 59-74.
23. Gauson, E.J., Donaldson, M.M., Dornan, E.S., Wang, X., Bristol, M., Bodily, J.M., and Morgan, I.M. (2015). Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication. J. Virol. 89, 4980-4991.
24. Gautam, D. and Moody, C.A. (2016). Impact of the DNA damage response on human papillomavirus chromatin. PLoS Pathog 12, e1005613.
25. Gillespie, K.A., Mehta, K.P., Laimins, L.A., and Moody, C.A. (2012). Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J. Virol. 86, 9520-9526.
26. Harris, L., McFarlane-Majeed, L., Campos-Leon, K., Roberts, S., and Parish, J.L. (2017). The cellular DNA helicase ChlR1 regulates chromatin and nuclear matrix attachment of the human papillomavirus 16 E2 protein and high-copy-number viral genome establishment. J. Virol. 91, e01853-16.
27. Helfer, C.M., Wang, R., and You, J. (2013). Analysis of the papillomavirus E2 and bromodomain protein Brd4 interaction using bimolecular fluorescence complementation. PLoS One 8, e77994.
28. Helfer, C.M., Yan, J., and You, J. (2014). The cellular bromodomain protein Brd4 has multiple functions in E2-mediated papillomavirus transcription activation. Viruses 6, 3228-3249.
29. Iftner, T., Haedicke-Jarboui, J., Wu, S.Y., and Chiang, C.M. (2016). Involvement of Brd4 in different steps of the papillomavirus life cycle. Virus Res. 231, 76-82.
30. Ilves, I., Kivi, S., and Ustav, M. (1999). Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which is mediated by the viral E2 protein and its binding sites. J. Virol. 73, 4404-4412.
31. Jang, M.K., Kwon, D., and McBride, A.A. (2009). Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin. J. Virol. 83, 2592-2600.
32. Jang, M.K., Shen, K., and McBride, A.A. (2014). Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome. PLoS Pathog. 10, e1004117.
33. Kanginakudru, S., DeSmet, M., Thomas, Y., Morgan, I.M., and Androphy, E.J. (2015). Levels of the E2 interacting protein TopBP1 modulate papillomavirus maintenance stage replication. Virology 478, 129-135.
34. Klumpp, D.J. and Laimins, L.A. (1999). Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology 257, 239-246.
35. Lambert, P.F., McBride, A., and Bernard, H.U. (2013). Special issue: The papillomavirus episteme. Virology 445, 1-1.
36. Lee, D., Kim, H., Lee, Y., and Choe, J. (1997). Identification of sequence requirement for the origin of DNA replication in human papillomavirus type 18. Virus Res 52, 97-108.
37. Lo Piano, A., Martinez-Jimenez, M.I., Zecchi, L., and Ayora, S. (2011). Recombination-dependent concatemeric viral DNA replication. Virus Res 160, 1-14.
38. Lopez-Bueno, A., Mavian, C., Labella, A.M., Castro, D., Borrego, J.J., Alcami, A., and Alejo, A. (2016). Concurrence of iridovirus, polyomavirus, and a unique member of a new group of fish papillomaviruses in lymphocystis disease-affected gilthead sea bream. J. Virol. 90, 8768-8779.
39. Maglennon, G.A., McIntosh, P., and Doorbar, J. (2011). Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology 414, 153-163.
40. McBride, A.A. (2008). Replication and partitioning of papillomavirus genomes. Adv. Virus Res. 72, 155-205.
41. McBride, A.A. (2013). The papillomavirus E2 proteins. Virology 445, 57-79.
42. McBride, A.A. and Jang, M.K. (2013). Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses 5, 1374-1394.
43. McBride, A.A. and Warburton, A. (2017). The Role of Integration in Oncogenic Progression of HPV associated cancers. PLos Pathog. 13, e1006211.
44. McKinney, C.C., Hussmann, K.L., and McBride, A.A. (2015). The role of the DNA damage response throughout the papillomavirus life cycle. Viruses 7, 2450-2469.
45. McKinney, C.C., Kim, M.J., Chen, D., and McBride, A.A. (2016). Brd4 activates early viral transcription upon human papillomavirus 18 infection of primary keratinocytes. mBio 7, e01644-16.
46. McPhillips, M.G., Ozato, K., and McBride, A.A. (2005). Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J. Virol. 79, 8920-8932.
47. McPhillips, M.G., Oliveira, J.G., Spindler, J.E., Mitra, R., and McBride, A.A. (2006). Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80, 9530-9543.
48. McShan, G.D. and Wilson, V.G. (1997). Reconstitution of a functional bovine papillomavirus type 1 origin of replication reveals a modular tripartite replicon with an essential AT-rich element. Virology 237, 198-208.
49. Mohr, I.J., Clark, R., Sun, S., Androphy, E.J., MacPherson, P., and Botchan, M.R. (1990). Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250, 1694-1699.
50. Moody, C.A. and Laimins, L.A. (2009). Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog 5, e1000605.
51. Nakahara, T., Peh, W.L., Doorbar, J., Lee, D., and Lambert, P.F. (2005). Human papillomavirus type 16 E1-E4 contributes to multiple facets of the papillomavirus life cycle. J. Virol. 79, 13150-13165.
52. Oliveira, J.G., Colf, L.A., and McBride, A.A. (2006). Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc. Natl. Acad. Sci. USA 103, 1047-1052.
53. Orav, M., Geimanen, J., Sepp, E.M., Henno, L., Ustav, E., and Ustav, M. (2015). Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms. Sci. Rep. 5, 15952.
54. Ozbun, M.A. (2002). Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription. J. Virol. 76, 11291-11300.
55. Parish, J.L., Bean, A.M., Park, R.B., and Androphy, E.J. (2006). ChlR1 Is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol. Cell 24, 867-876.
56. Piirsoo, M., Ustav, E., Mandel, T., Stenlund, A., and Ustav, M. (1996). Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. EMBO J. 15, 1-11.
57. Porter, S.S., Stepp, W.H., Stamos, J.D., and McBride, A.A. (2017). Host cell restriction factors that limit transcription and replication of human papillomavirus. Virus Res. 231, 10-20.
58. Pyeon, D., Pearce, S.M., Lank, S.M., Ahlquist, P., and Lambert, P.F. (2009). Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 5, e1000318.
59. Rahman, S., Sowa, M.E., Ottinger, M., Smith, J.A., Shi, Y., Harper, J.W., and Howley, P.M. (2011). The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell Biol. 31, 2641-2652.
60. Reinson, T., Toots, M., Kadaja, M., Pipitch, R., Allik, M., Ustav, E., and Ustav, M. (2013). Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J. Virol. 87, 951-964.
61. Remm, M., Brain, R., and Jenkins, J.R. (1992). The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res. 20, 6015-6021.
62. Russell, J. and Botchan, M.R. (1995). cis-Acting components of human papillomavirus (HPV) DNA replication: linker substitution analysis of the HPV type 11 origin. J. Virol. 69, 651-660.
63. Sakakibara, N., Mitra, R., and McBride, A.A. (2011). The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 85, 8981-8995.
64. Sakakibara, N., Chen, D., Jang, M.K., Kang, D.W., Luecke, H.F., Wu, S.Y., Chiang, C.M., and McBride, A.A. (2013a). Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA. PLoS Pathog. 9, e1003777.
65. Sakakibara, N., Chen, D., and McBride, A.A. (2013b). Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells. PLoS Pathog. 9, e1003321.
66. Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjose, S., Fakhry, C., Monk, B.J., Stanley, M.A., and Franceschi, S. (2016). Carcinogenic human papillomavirus infection. Nature reviews. Dis. Primers 2, 16086.
67. Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., and zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
68. Schweiger, M.R., Ottinger, M., You, J., and Howley, P.M. (2007). Brd4 independent transcriptional repression function of the papillomavirus E2 proteins. J. Virol. 81, 9612-9622.
69. Senechal, H., Poirier, G.G., Coulombe, B., Laimins, L.A., and Archambault, J. (2007). Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358, 10-17.
70. Skiadopoulos, M.H. and McBride, A.A. (1998). Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J. Virol. 72, 2079-2088.
71. Smith, J.A., White, E.A., Sowa, M.E., Powell, M.L., Ottinger, M., Harper, J.W., and Howley, P.M. (2010). Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad Sci. USA 107, 3752-3757.
72. Stanley, M.A. (2012). Epithelial cell responses to infection with human papillomavirus. Clinical microbiology reviews 25, 215-222.
73. Stenlund, A. (2003). Initiation of DNA replication: lessons from viral initiator proteins. Nat. Rev. Mol. Cell Biol. 4, 777-785.
74. Stepp, W.H., Meyers, J.M., and McBride, A.A. (2013). Sp100 provides intrinsic immunity against human papillomavirus infection. mBio 4, e00845-00813.
75. Straub, E., Dreer, M., Fertey, J., Iftner, T., and Stubenrauch, F. (2014). The viral E8-E2C repressor limits productive replication of human papillomavirus 16. J. Virol. 88, 937-947.
76. Stubenrauch, F., Colbert, A.M., and Laimins, L.A. (1998). Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J. Virol. 72, 8115-8123.
77. Sun, Y.N., Lu, J.Z., and McCance, D.J. (1996). Mapping of HPV-11 E1 binding site and determination of other important cis elements for replication of the origin. Virology 216, 219-222.
78. Thorland, E.C., Myers, S.L., Persing, D.H., Sarkar, G., McGovern, R.M., Gostout, B.S., and Smith, D.I. (2000). Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 60, 5916-5921.
79. Ustav, M. and Stenlund, A. (1991). Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10, 449-457.
80. Ustav, M., Ustav, E., Szymanski, P., and Stenlund, A. (1991). Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 10, 4321-4329.
81. Ustav, E., Ustav, M., Szymanski, P., and Stenlund, A. (1993). The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc. Natl. Acad Sci. USA 90, 898-902.
82. Ustav, M., Jr., Castaneda, F.R., Reinson, T., Mannik, A., and Ustav, M. (2015). Human papillomavirus type 18 cis-elements crucial for segregation and latency. PLoS One 10, e0135770.
83. Van Doorslaer, K. (2013). Evolution of the papillomaviridae. Virology 445, 11-20.
84. Van Doorslaer, K., Li, Z., Xirasagar, S., Maes, P., Kaminsky, D., Liou, D., Sun, Q., Kaur, R., Huyen, Y., and McBride, A.A. (2017). The Papillomavirus Episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res. 45, D499-D506.
85. Wang, J.W. and Roden, R.B. (2013). L2, the minor capsid protein of papillomavirus. Virology 445, 175-186.
86. Wang, X., Helfer, C.M., Pancholi, N., Bradner, J.E., and You, J. (2013). Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J. Virol. 87, 3871-3884.
87. Wu, S.Y., Lee, A.Y., Hou, S.Y., Kemper, J.K., Erdjument-Bromage, H., Tempst, P., and Chiang, C.M. (2006). Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20, 2383-2396.
88. You, J., Croyle, J.L., Nishimura, A., Ozato, K., and Howley, P.M. (2004). Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117, 349-360.